The weaker backdrop means the FTSE 100 index is forecast to give up all yesterday’s rise, with futures pointing to a decline ...

GSK Plc said its blood cancer drug significantly reduced the risk of death when combined with another cancer treatment, ...

GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...

GSK CEO Emma Walmsley said the sector would need to wait to see who is appointed in key roles in the Trump administration to ...

GSK fell 3.9% and AstraZeneca shed 3.1% ... Brent oil was quoted lower at USD72.08 a barrel late on Friday afternoon, down from USD72.43 at the time of the London equities close on Thursday. Gold was ...

London stocks had popped into the black by midday on Friday but gains were marginal as pharma shares took a hit and as data ...

Major companies like pharma giant GlaxoSmithKline (GSK) have established their largest AI teams in London. The city is a global leader in AI talent, as well as home to leading AI research centres, ...

UK pharma group posts ‘statistically significant’ trial results for treatment combined with Blenrep pulled in 2022 ...

London stocks fell in early trade on Friday as data showed that economic growth in the UK unexpectedly slowed in the third ...

The UK’s benchmark FTSE 100 index fell on Wednesday, dragged by healthcare shares after GSK warned of lower annual vaccine ...

Quarterly sales of GSK's RSV vaccine dropped more than 70%, following narrower recommendations for who should get the shot.